Providing Today's Patients with Medicines of the Future.
Staff
2017-2019 Net Profit CAGR
Current Brands of Products
Innovative Product Candidates
Covering Class III Hospitals
Covering Other Hospitals & Medical Institutions
April 8 2026, Simcere Zaiming announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for SIM0505, for the treat...
March 30, 2026 — Simcere Pharmaceutical Group Limited (2096.HK) announced that Phase III results from the RADIANT-AD study of rademikibart, an investi...
From March 13 to 16, 2026, the 41st Annual Congress of the European Association of Urology (EAU26) was held in London, UK. Data from a Phase I/II clin...
On March 16, 2026, Simcere Pharmaceutical Group (2096.HK) announced that the Phase 3 clinical trial of deuremidevir hydrobromide dry suspension (devel...